Skip to main content
Clinical Trials/NCT02845141
NCT02845141
Completed
Not Applicable

Synthetic Bone Graft Substitute (Actifuse) vs. Autologous Spongiosa for Tunnel Enlargement in Revision Anterior Cruciate Ligament Reconstruction - a Histological and Radiological Assessment

Berufsgenossenschaftliche Unfallklinik Ludwigshafen1 site in 1 country40 target enrollmentMarch 2013

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Anterior Cruciate Ligament Injury
Sponsor
Berufsgenossenschaftliche Unfallklinik Ludwigshafen
Enrollment
40
Locations
1
Primary Endpoint
histological assessment of bony consolidation
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

The overall objective is the histological and radiological assessment of bony consolidation of the tibial/femoral tunnel using either bone graft substitute (Actifuse) or autologous spongiosa in patients undergoing revision anterior cruciate ligament reconstruction.

Clinical correlation with the histological and radiological results using the SF36 questionnaire.

Detailed Description

\* Study design: Monocentric, prospective, randomised study. Patients who need revision anterior cruciate ligament reconstruction and show a tunnel enlargement of \>10mm will have a first operation filling the tibial/femoral tunnel either with bone graft substitute (Actifuse) or autologous spongiosa. 5 - 6 months after this first operation a CT will be performed to assess the bony consolidation of the former tibial/femoral tunnel. An MRI will be performed to assess vitality of the bone substitute. An osseous biopsy will be taken from the tibial/femoral tunnel at the revision anterior cruciate ligament reconstruction approximately 6 months after bone grafting. Clinical evaluation will be performed 6 weeks, 3 months and 6 months postoperative. At 6 months postoperative additional radiological evaluation and clinical assessment using the SF36 questionnaire will be performed. * Treatment: Either autologous spongiosa or Actifuse (MIS applicator) will be administered by the investigator as a bone graft substitute for tunnel enlargement in patients undergoing revision anterior cruciate ligament reconstruction. * Duration of Participation: The participation of each subject will be approximately 12 months. Each subject will undergo revision anterior cruciate ligament reconstruction approximately 6 months after bone grafting. A biopsy will be taken at this operation. A clinical and radiological follow up is planned for further 6 months. \* Subjects: Male and female patients ≥ 18 years. Approximately 40 patients who undergo revision anterior cruciate ligament reconstruction will be included in the study. Inclusion criteria: Patients in need of revision anterior cruciate ligament reconstruction Exclusion criteria: Infection, wound healing complications

Registry
clinicaltrials.gov
Start Date
March 2013
End Date
July 2017
Last Updated
8 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Berufsgenossenschaftliche Unfallklinik Ludwigshafen
Responsible Party
Principal Investigator
Principal Investigator

Jan von Recum

Dr. med.

Berufsgenossenschaftliche Unfallklinik Ludwigshafen

Eligibility Criteria

Inclusion Criteria

  • Patients in need of revision anterior cruciate ligament reconstruction

Exclusion Criteria

  • Infection, wound healing complications

Outcomes

Primary Outcomes

histological assessment of bony consolidation

Time Frame: 6 months postop

histological probes during second intervention to measure bony ingrowth into bone substitute material

Secondary Outcomes

  • IKDC Score(3, 6 and 12 Months)
  • stability measurement using KT1000(3, 6 and 12 Months)
  • SF36-Score(3, 6 and 12 Months)
  • Tegner Activity Score(3, 6 and 12 Months)

Study Sites (1)

Loading locations...

Similar Trials